Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 671 of 767

Advanced search

🇺🇸Jun 24Researchclinicaltrials.govTier 1 · Trial registry

NCT00678821: Aerobic Exercise in Patients With Pulmonary Hypertension

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Nvidia bets on agentic AI to turbocharge biotech discovery

SiliconANGLEOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy

PharmaLiveOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

China’s biotech boom: record 5,215 clinical drug trials reported in 2025

South China Morning PostOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Key Takeaways | Leveraging China’s biotech ecosystem

McDermott Will & SchulteOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Fact check: Who did Eli Lilly give access to its obesity drug? White House says not Trump

IndyStarOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Diet pill death triggers raids

Bangkok PostOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Base-editing biotech launches straight onto NASDAQ in reverse merger with Boundless

FirstWord PharmaOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Reuters Health News Summary

DevdiscourseOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Biotech Blues & The Not-So-Hidden Costs of Prior Art: Lessons in Pharma and Psychedelics

JD SupraOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A

ETF DatabaseOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Biotech's Silent Resurgence (5-Year Base Breakout)

Yahoo FinanceOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Chlorthalidone Blood Pressure Drug Recalled Nationwide After FDA Warning

Evrim AğacıOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

FDA Pilot Targets Faster Early-Stage Drug Trial Starts | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines (RVMD) Initiates Phase 3 Trial for Pancreatic Cancer Treatment

GuruFocusOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Retail Investors Say Don’t Miss This Top Biotech Stock With Huge Upside Potential

Yahoo FinanceOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial

Sleep ReviewOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents

Pharmaceutical TechnologyOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Sen. Gillibrand Raises Concerns About China’s Ability To Attract U.S. Biotech Investment, Partners

Coalition For A Prosperous AmericaOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Haisco licenses two drug candidates to Nuvectis for $40m upfront

Investing.com UKOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Exclusive | Pro-life groups press Todd Blanche to settle FDA mail-in abortion pill case: ‘Unborn children are killed’

New York PostOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Haisco licenses two drug candidates to Nuvectis for $40m upfront By Investing.com

Investing.com AustraliaOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Trade Group Files Lawsuits to Block State Laws on PBMs

planadviserOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push

Fierce BiotechOriginal source

🌍Jun 24CROcrucialdatasolutions.comTier 2 · Direct publisher

How Protocol Design Decisions Shape Recruitment, Data Quality & Study Startup

TrialKitOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Galectin reaches FDA agreement on Phase 3 trial for belapectin By Investing.com

Investing.com South AfricaOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Serapha Bio takes flight from Boundless merger with $230M and gene-editing prospect from China

Fierce BiotechOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines begins phase 3 trial for pancreatic cancer By Investing.com

Investing.com South AfricaOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy

Pharmaceutical TechnologyOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy

BioSpaceOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Cantor Fitzgerald reiterates Crescent Biopharma stock rating

Investing.com UKOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Pro-Life Doctors Urge FDA to Reinstate Abortion Pill Safeguards

Daily SignalOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Verrica stock rating on trial progress

Investing.com UKOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Verrica stock rating on trial progress By Investing.com

Investing.com South AfricaOriginal source

🇺🇸Jun 24Devicesorthopediatrics.comTier 1 · Company source

ApiFix®

OrthoPediatricsOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Retatrutide: What To Know About Online Sales, Safety Risks and More

ForbesOriginal source

🌍Jun 24discoverynews.google.comTier 3 · Aggregated media

Sanofi Multiple Sclerosis Drug Gets EU Approval Despite FDA Letter - Sanofi (NASDAQ:SNY)

BenzingaOriginal source

🌍Jun 24discoverynews.google.comTier 2 · Trade media

Pfizer drug acquired in Seagen deal disappoints in lung cancer study

BioPharma DiveOriginal source

🇺🇰Jun 24Regulatorygov.ukTier 1 · Regulatory source

Urgent public health messages

Public health messages to all NHS service providers.

UK Health Security AgencyOriginal source

🇺🇰Jun 24Regulatorygov.ukTier 1 · Regulatory source

Personal protective equipment and heat: risk of heat stress

This is an urgent public health message to health and care providers and professionals regarding the...

UK Health Security AgencyOriginal source

🇪🇺Jun 23Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Spatial Crosstalk in Immuno-Oncology

CORDISOriginal source

🇺🇰Jun 23Regulatorygov.ukTier 1 · Regulatory source

National norovirus and rotavirus report, week 27 report: data to week 26 (data up to 28 June 2026)

Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England du...

UK Health Security AgencyOriginal source

🇺🇰Jun 23Regulatorygov.ukTier 1 · Regulatory source

Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, May 2025 to May 2026

Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resista...

UK Health Security AgencyOriginal source

🇺🇰Jun 23Regulatorygov.ukTier 1 · Regulatory source

Reforming the General Medical Council legislative framework

Seeks views on the draft General Medical Council Order 2026.

UK Department of Health and Social CareOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis

NeurologyLiveOriginal source

🇪🇸Jun 23Industryrovi.esTier 1 · Company source

Huella hídrica

Laboratorios RoviOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

Indian Pharma PostOriginal source

🇺🇰Jun 23Regulatorygov.ukTier 1 · Regulatory source

Adult social care data collection: September 2025 notice

Information about the mandated national adult social care data returns for the year 2025 to 2026.

UK Department of Health and Social CareOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Ocugen completes OCU400 Phase 3 enrollment, shares trade in tight NASDAQ range

Ad-hoc-news.deOriginal source

🌍Jun 23discoverynews.google.comTier 2 · Trade media

Atom Therapeutics Announces First Patient Dosed in China Phase 3 Clinical Trial of Lingdolinurad (ABP-671) for Chronic Gout

BioSpaceOriginal source

🌍Jun 23discoverynews.google.comTier 2 · Trade media

Merck KGaA pledges $50M to new biotech with eye to acquisition

Fierce BiotechOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Pfizer lung cancer drug sigvotatug vedotin fails phase 3 trial

qz.comOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Pfizer (PFE) Lung Cancer Drug Misses Survival Goal In Phase 3 Trial

Yahoo FinanceOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach

Cannabis Health NewsOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

FDA Pilot Targets Faster Early-Stage Drug Trial Starts

Pharmaceutical ExecutiveOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

What Operation TrialBlazer means for CDMOs and CMC strategy

Manufacturing ChemistOriginal source

🌍Jun 23Mediaheartsciences.comTier 2 · Direct publisher

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

HeartSciencesOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications

The Manila TimesOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Measuring the Pull-Side Innovation Burden for Pharmaceutical Drugs by OECD Country

HHS.govOriginal source

🌍Jun 23discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines begins phase 3 trial for pancreatic cancer

Investing.comOriginal source